Clinical Trials Directory

Trials / Completed

CompletedNCT02565953

Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Balloon Catheter vs PTA Balloon

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
134 (actual)
Sponsor
Fundación Pública Andaluza Progreso y Salud · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

In recent years the use of paclitaxel releasing percutaneous transluminal angioplastic (PTA) balloon catheter is spreading in vascular pathology, mainly in stenosis infrainguinal arteries. This device combined the mechanical action of PTA balloon with the antiproliferative effects of paclitaxel. The use of these devices in venous pathology is limited. This devices could improve the treatment of renal dialysis arteriovenous fistula stenosis.

Conditions

Interventions

TypeNameDescription
DEVICEPaclitaxel-releasing PTA balloon catheter
DEVICEPTA balloon catheter

Timeline

Start date
2015-10-01
Primary completion
2018-10-01
Completion
2018-10-01
First posted
2015-10-01
Last updated
2019-02-22

Locations

4 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT02565953. Inclusion in this directory is not an endorsement.

Primary Patency in Post-angioplasty Dysfunctional Arteriovenous Fistula in Renal Dialysis: Paclitaxel-releasing PTA Ball (NCT02565953) · Clinical Trials Directory